Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Capital Employed (2019 - 2025)

Eton Pharmaceuticals' Return on Capital Employed history spans 7 years, with the latest figure at 0.01% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 28.0% year-over-year to 0.01%; the TTM value through Sep 2025 reached 0.01%, up 28.0%, while the annual FY2024 figure was 0.02%, 1.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.01% at Eton Pharmaceuticals, down from 0.02% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.39% in Q3 2023 and bottomed at 0.57% in Q2 2022.
  • The 5-year median for Return on Capital Employed is 0.07% (2021), against an average of 0.16%.
  • The largest annual shift saw Return on Capital Employed skyrocketed 184bps in 2021 before it plummeted -73bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.07% in 2021, then plummeted by -69bps to 0.11% in 2022, then surged by 92bps to 0.01% in 2023, then tumbled by -136bps to 0.02% in 2024, then skyrocketed by 33bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ETON's Return on Capital Employed are 0.01% (Q3 2025), 0.02% (Q2 2025), and 0.01% (Q1 2025).